Mutual of America Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Mutual of America Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,816	Closed	-$39.9K	–	1474
2022 Q4	$39.9K	Buy	14,816 +756	+5%	+$2.21K	﹤0.01%	1452
2022 Q3	$46K	Buy	14,060 +3,433	+32%	+$15.5K	﹤0.01%	1610
2022 Q2	$52K	Buy	10,627 +1,544	+17%	+$9.5K	﹤0.01%	1597
2022 Q1	$69K	Buy	9,083 +470	+5%	+$3.64K	﹤0.01%	1586
2021 Q4	$80K	Buy	8,613 +210	+2%	+$2.23K	﹤0.01%	1574
2021 Q3	$120K	Buy	8,403 +1,294	+18%	+$20.1K	﹤0.01%	1481
2021 Q2	$118K	Buy	+7,109	New	+$133K	﹤0.01%	1529

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Mutual of America Capital Management's ORGO Position: Q1 2023 in Review

Mutual of America Capital Management sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 14,816 shares — an estimated $39.9K sold.

Mutual of America Capital Management first reported a position in ORGO in Q2 2021 and held it in 7 quarters. The position peaked at $120K in Q3 2021. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

Mutual of America Capital Management reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
Mutual of America Capital Management sold 14,816 Organogenesis Holdings shares in Q1 2023, an estimated $39.9K.
Mutual of America Capital Management first reported a position in Organogenesis Holdings in Q2 2021 and held it in 7 quarters.
Mutual of America Capital Management's Organogenesis Holdings position peaked at $120K in Q3 2021.
131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Mutual of America Capital Management's 13F filing for Q1 2023, filed 4 May 2023.